Exploring the prediction of emotional valence and pharmacologic effect across fMRI studies of antidepressants

Background: Clinically approved antidepressants modulate the brain's emotional valence circuits, suggesting that the response of these circuits could serve as a biomarker for screening candidate antidepressant drugs. However, it is necessary that these modulations can be reliably detected. Here...

Full description

Bibliographic Details
Main Authors: Daniel S. Barron, Mehraveh Salehi, Michael Browning, Catherine J. Harmer, R. Todd Constable, Eugene Duff
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:NeuroImage: Clinical
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158218302572